Skip Menu

Return to Skip Menu

Main Content

Other Lab Collaborations

 

Publications

Halliburton, A. E., & Fritz, M. S. (2017). Health beliefs as a key determinant of intent to use anabolic-androgenic steroids (AAS) among high school football players: Implications for prevention. International Journal of Adolescence and Youth.

Halliburton, A. E., Ridenour, T. A., White, B. A., & Deater-Deckard, K. (2017). Clinically differentiating life-course-persistent and adolescence-limited conduct problems: Is age-of-onset really enough? Journal of Applied Developmental Psychology, 52, 34-45.

Halliburton, A. E., & Bray, B. (2016). Long-term prevalence and demographic trends in U.S. adolescent inhalant use: Implications for clinicians and prevention scientists. Substance Use and Misuse.

Ridenour, T. A., Halliburton, A. E., & Bray, B. C. (2015). Does DSM-5 nomenclature for inhalant use disorder improve upon DSM-IV? Psychology of Addictive Behaviors, 29(1), 211-217.


Presentations

Halliburton, A. E., Ridenour, T. A., White, B. A., & Deater-Deckard, K. (2015, November). Differentiating life-course-persistent and adolescence-limited conduct problems: An evaluation of risk factors in a chronically stressed sample of youth. Poster presented at the Association for Behavioral and Cognitive Therapies 49th Annual Convention, Chicago, IL.

Halliburton, A. E., Fritz, M. S., MacKinnon, D. P., Goldberg, L., Elliot, D., & Moe, E. (2015, November). Unpacking the ATLAS program: Conditional process modeling of steroid use among high school football players. Poster presented at the Association for Behavioral and Cognitive Therapies 49th Annual Convention, Chicago, IL.

Swain, D. M., Gordon, H., Cooper, L.D., & Scarpa, A. (2015, May). The mediating role of empathy on broader autism traits and prosocial behavior.  Poster presented at the International Meeting for Autism Research in Salt Lake City, Utah.

Halliburton, A. E., & Bray, B. C. (2013, November). Long-term trends in U.S. adolescent inhalant use: Prevalence rates and influences of drug policy. Poster presented at the Association for Behavioral and Cognitive Therapies 47th Annual Convention, Nashville, TN.

Halliburton, A. E., Bray, B. C., & Ridenour, T. A. (2013, May). Testing the validity of the anticipated DSM-5 inhalant use disorder diagnosis: An item response theory analysis. Paper presented at the Society for Prevention Research 21st Annual Meeting, San Francisco, CA.